Roche Group Sales Rise 7% YoY To CHF 61.516B ($76.963B) At Constant Exchange Rates And Core EPS Grows 11% To CHF 19.46 ($24.35)

Benzinga01-29

Key figures	CHF millions		% change
January–December	2025	2024	At CER1	In CHF
Group sales	61,516	60,495	7	2
Pharmaceuticals Division	47,669	46,171	9	3
Diagnostics Division	13,847	14,324	2	-3
Core operating profit	21,833	20,823	13	5
Core EPS – diluted (CHF)	19.46	18.80	11	4
IFRS net income	13,799	9,187	58	50

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2607487708?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-29 14:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2607487708","market":"hk","top_or_hot":-1,"title":"Roche Group Sales Rise 7% YoY To CHF 61.516B ($76.963B) At Constant Exchange Rates And Core EPS Grows 11% To CHF 19.46 ($24.35)","media":"Benzinga","content":"<html><body><figure><table><tbody><tr><td><strong>Key figures</strong></td><td colspan=\"2\"><strong>CHF millions</strong></td><td colspan=\"2\"><strong>% change</strong></td></tr><tr><td><strong>January–December</strong></td><td><strong>2025</strong></td><td><strong>2024</strong></td><td><strong>At CER1</strong></td><td><strong>In CHF</strong></td></tr><tr><td>Group sales</td><td>61,516</td><td>60,495</td><td>7</td><td>2</td></tr><tr><td>Pharmaceuticals Division</td><td>47,669</td><td>46,171</td><td>9</td><td>3</td></tr><tr><td>Diagnostics Division</td><td>13,847</td><td>14,324</td><td>2</td><td>-3</td></tr><tr><td>Core operating profit</td><td>21,833</td><td>20,823</td><td>13</td><td>5</td></tr><tr><td>Core EPS – diluted (CHF)</td><td>19.46</td><td>18.80</td><td>11</td><td>4</td></tr><tr><td>IFRS net income</td><td>13,799</td><td>9,187</td><td>58</td><td>50</td></tr></tbody></table></figure></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Roche Group Sales Rise 7% YoY To CHF 61.516B ($76.963B) At Constant Exchange Rates And Core EPS Grows 11% To CHF 19.46 ($24.35)</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRoche Group Sales Rise 7% YoY To CHF 61.516B ($76.963B) At Constant Exchange Rates And Core EPS Grows 11% To CHF 19.46 ($24.35)\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2026-01-29 14:46</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><figure><table><tbody><tr><td><strong>Key figures</strong></td><td colspan=\"2\"><strong>CHF millions</strong></td><td colspan=\"2\"><strong>% change</strong></td></tr><tr><td><strong>January–December</strong></td><td><strong>2025</strong></td><td><strong>2024</strong></td><td><strong>At CER1</strong></td><td><strong>In CHF</strong></td></tr><tr><td>Group sales</td><td>61,516</td><td>60,495</td><td>7</td><td>2</td></tr><tr><td>Pharmaceuticals Division</td><td>47,669</td><td>46,171</td><td>9</td><td>3</td></tr><tr><td>Diagnostics Division</td><td>13,847</td><td>14,324</td><td>2</td><td>-3</td></tr><tr><td>Core operating profit</td><td>21,833</td><td>20,823</td><td>13</td><td>5</td></tr><tr><td>Core EPS – diluted (CHF)</td><td>19.46</td><td>18.80</td><td>11</td><td>4</td></tr><tr><td>IFRS net income</td><td>13,799</td><td>9,187</td><td>58</td><td>50</td></tr></tbody></table></figure></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RHHBF","symbol_name":"Roche Holding Ltd","start_time":0,"source_url":"https://www.benzinga.com/news/earnings/26/01/50216168/roche-group-sales-rise-7-yoy-to-chf-61-516b-76-963b-at-constant-exchange-rates-and-core-eps-grows-1","article_id":"2607487708","we_media_id":"1052270027","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2607487708","pubTimestamp":1769669208,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Benzinga","introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"summary":"Key figuresCHF millions% changeJanuary–December20252024At CER1In CHFGroup sales61,51660,49572Pharmaceuticals Division47,66946,17193Diagnostics Division13,84714,3242-3Core operating profit21,83320,823135Core EPS – diluted","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"RHHBF":"Roche Holding Ltd","BK4007":"制药","03165":"华夏欧优股对冲","RHHBY":"罗氏控股","RHHVF":"Roche Holding Ltd"},"translate_title":"按固定汇率计算，罗氏集团销售额同比增长7%至61.516 B瑞士法郎($76.963 B)，核心每股收益增长11%至19.46瑞士法郎($24.35)","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03165":0.6,"RHHBY":0.9,"RHHVF":0.9,"RHHBF":0.9},"content_text":"Key figuresCHF millions% changeJanuary–December20252024At CER1In CHFGroup sales61,51660,49572Pharmaceuticals Division47,66946,17193Diagnostics Division13,84714,3242-3Core operating profit21,83320,823135Core EPS – diluted (CHF)19.4618.80114IFRS net income13,7999,1875850","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport,express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2607487708","isCrawlerRequest":true}